
Here: an overview of atezolizumab, the first new drug in two decades for bladder cancer and now approved for NSCLC.
2017 PharmD Candidate at University of Connecticut School of Pharmacy, Storrs, Conn.
Here: an overview of atezolizumab, the first new drug in two decades for bladder cancer and now approved for NSCLC.
Published: February 8th 2017 | Updated: